Webinar description

Join MAPS Canada for an exclusive conversation with leaders from some of Canada's licensed psychedelic producers. Hear from the people behind the molecules to explore what's being made, who's using it, and what the future of legal psychedelics may hold in Canada and beyond.

    1. Straight from the Source: Hear from Canada’s Psychedelic Manufacturers

About this webinar

  • $10.00
  • 1 hour of video content

Panelists

  • Danny Motyka, Co-Founder & CEO, Psygen

  • Nick Kadysh, CEO, PharmAla Biotech

  • Roya Barghian, Mycologist & Master Grower, Shields Pharma Inc.

Hosts

  • Rielle Capler, Executive Director, MAPS Canada

  • Sonia Brodie, Board Member, MAPS Canada

Learning Objectives

  • Which psychedelic substances are currently being legally produced in Canada and for what purposes

  • Current and emerging therapeutic and research applications of legal psychedelics

  • Key challenges facing psychedelic producers in the Canadian regulatory environment

  • How industry leaders see the landscape evolving over the next one to five years

Start your learning journey

Enroll today

Categories